Transcriptomics

Dataset Information

0

Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer


ABSTRACT: Although FDG-PET is widely used in cancer, its role in gastric cancer (GC) is still controversial due to variable [18F]fluorodeoxyglucose ([18F]FDG) uptake. Here, we investigate the molecular landscape of GC and its association with glucose metabolic profiles noninvasively evaluated by [18F]FDG PET. Based on a genetic signature, PETscore, representing [18F]FDG avidity, was developed by imaging data acquired from thirty patient-derived xenografts (PDX). Five genes, PLS1, PYY, HBQ1, SLC6A5, NAT16, were identified for the PETscore, which was validated in independent cohorts by qRT-PCR and RNA-sequencing. By applying the PETscore on the Cancer Genome Atlas (TCGA), a significant association between glucose uptake and tumor mutational burden as well as genomic alterations was identified in GC. Our findings suggest that molecular characteristics are underlying the diverse metabolic profiles of GC. Diverse glucose metabolic profiles may apply to precise diagnostic and therapeutic approaches for GC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE164961 | GEO | 2022/04/05

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-09-08 | GSE150934 | GEO
2023-04-14 | GSE227581 | GEO
2020-03-18 | GSE135565 | GEO
2012-12-20 | E-GEOD-34807 | biostudies-arrayexpress
2020-03-18 | GSE131769 | GEO
2022-11-29 | GSE218758 | GEO
2012-12-20 | GSE34807 | GEO
2022-02-16 | PXD028806 | Pride
2015-02-09 | E-MTAB-3175 | biostudies-arrayexpress
2023-11-01 | GSE161404 | GEO